Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies

This study has been completed.
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance Identifier:
First received: March 26, 2009
Last updated: January 15, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)